We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M Turnover 56.25%
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+35.27%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$23.7M
Cap. Flow
-$10.9M
Cap. Flow %
-7.21%
Top 10 Hldgs %
49.48%
Holding
78
New
25
Increased
14
Reduced
22
Closed
12
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
AVAV icon
AeroVironment
AVAV
+$3.78M
2
AXGN icon
Axogen
AXGN
+$2.78M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$2.41M
4
DRRX icon
DURECT Corp
DRRX
+$2.36M
5
CUTR icon
Cutera, Inc.
CUTR
+$1.95M

Top Sells

Rank Stock Value
1
BEAT icon
BioTelemetry, Inc.
BEAT
+$7.34M
2
MSTR icon
Strategy Inc
MSTR
+$4.07M
3
RPRX icon
Repros Therapeutics Inc.
RPRX
+$3.69M
4
UI icon
Ubiquiti
UI
+$3.4M
5
COA
COASTAL CONTACTS INC COMMON SHARES (CANADA)
COA
+$2.89M

Sector Composition

Rank Sector Weight
1 Healthcare 50.2%
2 Technology 28.6%
3 Communication Services 5.65%
4 Industrials 3.78%
5 Materials 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CALX icon
1
Calix
CALX
$2.27B
$12.2M 8.06%
957,806
-126,400
-12% -$1.55M
2013 Q2
1 quarter
LSAK icon
2
Lesaka Technologies
LSAK
$384M
$10.2M 6.73%
848,766
-99,800
-11% -$901K
2013 Q2
1 quarter
BEAT icon
3
DELISTED
BioTelemetry, Inc.
BEAT
$10M 6.64%
1,013,318
-932,354
-48% -$7.34M
2013 Q2
1 quarter
MSTR icon
4
Strategy Inc
MSTR
$60.7B
$8.58M 5.67%
826,630
-418,000
-34% -$4.07M
2013 Q2
1 quarter
BDSI
5
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$8.01M 5.3%
1,474,906
– –
2013 Q2
1 quarter
TLPH icon
6
Talphera
TLPH
$55M
$5.86M 3.88%
27,189
-9,456
-26% -$2.06M
2013 Q2
1 quarter
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$5.59M 3.7%
619,604
+36,386
+6% +$270K
2013 Q2
1 quarter
PKT
8
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$5.03M 3.33%
324,700
+51,700
+19% +$733K
2013 Q2
1 quarter
MEET
9
DELISTED
The Meet Group, Inc. Common Stock
MEET
$4.7M 3.11%
2,595,039
+177,080
+7% +$310K
2013 Q2
1 quarter
SANW icon
10
DELISTED
S&W Seed Co
SANW
$4.64M 3.07%
29,169
-2,963
-9% -$445K
2013 Q2
1 quarter
SIGA icon
11
SIGA Technologies
SIGA
$223M
$4.46M 2.95%
1,167,185
-401,752
-26% -$1.38M
2013 Q2
1 quarter
SRPT icon
12
Sarepta Therapeutics
SRPT
$1.78B
$4.22M 2.79%
89,400
+62,600
+234% +$2.41M
2013 Q2
1 quarter
ARAY icon
13
Accuray
ARAY
$20.9M
$4.06M 2.69%
550,400
+202,634
+58% +$1.28M
2013 Q2
1 quarter
AVAV icon
14
AeroVironment
AVAV
$6.13B
$3.9M 2.58%
+169,426
New +$3.78M
2013 Q3
0 quarters
UI icon
15
Ubiquiti
UI
$36.7B
$3.73M 2.47%
111,063
-126,900
-53% -$3.4M
2013 Q2
1 quarter
AXGN icon
16
Axogen
AXGN
$2.06B
$3.36M 2.22%
+755,728
New +$2.78M
2013 Q3
0 quarters
PCYO icon
17
Pure Cycle
PCYO
$270M
$3.09M 2.04%
669,436
+98,052
+17% +$532K
2013 Q2
1 quarter
CUTR icon
18
DELISTED
Cutera, Inc.
CUTR
$2.89M 1.91%
324,337
+206,337
+175% +$1.95M
2013 Q2
1 quarter
SDEV icon
19
Stablecoin Development Corp
SDEV
$50.1M
$2.77M 1.83%
11
+4
+57% +$886K
2013 Q2
1 quarter
DRRX icon
20
DELISTED
DURECT Corp
DRRX
$2.67M 1.76%
+198,952
New +$2.36M
2013 Q3
0 quarters
CSII
21
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.64M 1.74%
131,541
-44,800
-25% -$933K
2013 Q2
1 quarter
RPRX icon
22
DELISTED
Repros Therapeutics Inc.
RPRX
$2.5M 1.65%
93,300
-172,000
-65% -$3.69M
2013 Q2
1 quarter
P icon
23
DELISTED
Pandora Media Inc
P
$2.44M 1.62%
97,200
+45,800
+89% +$938K
2013 Q2
1 quarter
SRL icon
24
Scully Royalty
SRL
$72.3M
$2.39M 1.58%
57,000
– –
2013 Q2
1 quarter
ARCT icon
25
Arcturus Therapeutics
ARCT
$316M
$2.09M 1.38%
+16,536
New +$1.47M
2013 Q3
0 quarters
1
2 3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Sophrosyne Capital held 78 positions worth $151M, up 19% from $128M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sophrosyne Capital withdrew a net $10.9M in Q3 2013, closing 12 positions and reducing 22 holdings. Its most notable exit was COASTAL CONTACTS INC COMMON SHARES (CANADA), an estimated $2.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 46% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Sophrosyne Capital opened a new position in AeroVironment worth $3.9M.

  • Sophrosyne Capital's largest Q3 2013 buy was AeroVironment: 169,426 shares worth $3.9M.
  • Sophrosyne Capital added most to Sarepta Therapeutics in Q3 2013, an estimated $2.41M increase.
  • Sophrosyne Capital's biggest Q3 2013 reduction was BioTelemetry, Inc., cutting an estimated $7.34M.
  • Sophrosyne Capital fully exited COASTAL CONTACTS INC COMMON SHARES (CANADA) in Q3 2013, selling an estimated $2.89M.
  • Sophrosyne Capital's ten largest holdings make up 49% of its $151M portfolio in Q3 2013.
  • Sophrosyne Capital opened 25 new positions and closed 12 in Q3 2013.
  • Sophrosyne Capital's portfolio value rose 19% quarter-over-quarter to $151M.

Based on Sophrosyne Capital's 13F filing for Q3 2013, filed 14 Nov 2013.